These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 37290688)

  • 21. Clostridioides difficile infection in patients with hematological malignancy: A multicenter study in Taiwan.
    Hung YP; Tsai CS; Tsai BY; Tsai PJ; Lee YT; Lee JC; Liu HC; Hsueh PR; Lee CC; Ko WC
    J Microbiol Immunol Infect; 2021 Dec; 54(6):1101-1110. PubMed ID: 33678554
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mortality, Health Care Use, and Costs of Clostridioides difficile Infections in Older Adults.
    Feuerstadt P; Nelson WW; Drozd EM; Dreyfus J; Dahdal DN; Wong AC; Mohammadi I; Teigland C; Amin A
    J Am Med Dir Assoc; 2022 Oct; 23(10):1721-1728.e19. PubMed ID: 35288083
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fecal Microbiota Transplant Decreases Mortality in Patients with Refractory Severe or Fulminant Clostridioides difficile Infection.
    Cheng YW; Phelps E; Nemes S; Rogers N; Sagi S; Bohm M; El-Halabi M; Allegretti JR; Kassam Z; Xu H; Fischer M
    Clin Gastroenterol Hepatol; 2020 Sep; 18(10):2234-2243.e1. PubMed ID: 31923639
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risk for Asymptomatic Household Transmission of Clostridioides difficile Infection Associated with Recently Hospitalized Family Members.
    Miller AC; Arakkal AT; Sewell DK; Segre AM; Pemmaraju SV; Polgreen PM;
    Emerg Infect Dis; 2022 May; 28(5):932-939. PubMed ID: 35447064
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An analysis of the outcomes of Clostridioides difficile occurring in intestinal transplant recipients requiring hospitalization.
    Amjad W; Schiano T; Segovia MC; Malik A; Weiner J; Horslen S; Jafri SM
    Transpl Infect Dis; 2023 Feb; 25(1):e13951. PubMed ID: 36621893
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Poor functional status as a risk factor for severe Clostridium difficile infection in hospitalized older adults.
    Rao K; Micic D; Chenoweth E; Deng L; Galecki AT; Ring C; Young VB; Aronoff DM; Malani PN
    J Am Geriatr Soc; 2013 Oct; 61(10):1738-42. PubMed ID: 24083842
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Effect of Saccharomyces boulardii Primary Prevention on Risk of Hospital-onset Clostridioides difficile Infection in Hospitalized Patients Administered Antibiotics Frequently Associated With C. difficile Infection.
    Wombwell E; Patterson ME; Bransteitter B; Gillen LR
    Clin Infect Dis; 2021 Nov; 73(9):e2512-e2518. PubMed ID: 32575126
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cost and length of hospital stay for healthcare facilityonset Clostridioides Difficile infection in pediatric wards: a prospective cohort analysis.
    Demir SÖ; Kepenekli E; Akkoç G; Yakut N; Soysal A
    Turk J Pediatr; 2021; 63(6):1004-1011. PubMed ID: 35023650
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Outcomes of
    Milenković B; Šuljagić V; Perić A; Dragojević-Simić V; Tarabar O; Milanović M; Putić V; Tomić D; Miljković B; Vezmar Kovačević S
    Eur J Hosp Pharm; 2022 Mar; 29(e1):e15-e22. PubMed ID: 33579720
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epidemiology of Clostridioides difficile infection in hospitalized patients in Spain: An eight-year review (2012-2019).
    Asensio Á; Vallejo-Plaza A; Parra LM; Ortí-Lucas R; Salcedo I; Ramos A; Cantero M;
    Enferm Infecc Microbiol Clin (Engl Ed); 2022 Mar; 40(3):125-130. PubMed ID: 35249672
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Outcome of Clostridioides difficile infections treated in a Swiss tertiary care hospital: an observational study.
    Haubitz S; Bartlomé N; Bucheli Laffer E; Spelters C; Fankhauser H; Fux CA
    Swiss Med Wkly; 2020 Jan; 150():w20173. PubMed ID: 31940431
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Healthcare-associated
    Manea E; Jipa R; Milea A; Roman A; Neagu G; Hristea A
    Rom J Intern Med; 2021 Dec; 59(4):409-415. PubMed ID: 34053203
    [No Abstract]   [Full Text] [Related]  

  • 33.
    MacKenzie EL; Murillo C; Bartlett AH; Marrs R; Landon EM; Ridgway JP
    Infect Control Hosp Epidemiol; 2023 Nov; 44(11):1782-1787. PubMed ID: 36658099
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative clinical outcomes evaluation of hospitalized patients infected with Clostridioides difficile ribotype 106 vs. other toxigenic strains.
    Almutairi MS; Gonzales-Luna AJ; Alnezary FS; Fallatah SB; Alam MJ; Begum K; Garey KW
    Anaerobe; 2021 Dec; 72():102440. PubMed ID: 34461273
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Performance of Clostridioides difficile infection severity scores and risk factors related to 30-day all-cause mortality in patients with cancer.
    De-la-Rosa-Martinez D; Zinser-Peniche P; Martin-Onraet A; Rivera-Buendía F; Vilar-Compte D
    Support Care Cancer; 2023 Feb; 31(3):187. PubMed ID: 36843052
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clostridium difficile infection is associated with increased risk of death and prolonged hospitalization in children.
    Sammons JS; Localio R; Xiao R; Coffin SE; Zaoutis T
    Clin Infect Dis; 2013 Jul; 57(1):1-8. PubMed ID: 23532470
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epidemiology and Outcomes of Patients With Healthcare Facility-Onset Clostridioides difficile Infection.
    Eberly MD; Susi A; Adams DJ; Love CS; Nylund CM
    Mil Med; 2022 Jul; 187(7-8):e915-e920. PubMed ID: 33772561
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of the COVID-19 pandemic on the incidence of healthcare facility-onset Clostridioides difficile infection in hospitalized patients with sepsis: Interrupted time series analysis using Japanese Diagnosis Procedure Combination data.
    Endo K; Mizuno K; Takeuchi M; Kawakami K
    Anaerobe; 2023 Feb; 79():102693. PubMed ID: 36623703
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The use of laboratory-identified event surveillance to classify adverse outcomes due to
    Shen Y; Ellison J; Leal J; Bush KR; Chandran AU; Fathima S; Conly JM
    Infect Control Hosp Epidemiol; 2021 May; 42(5):557-564. PubMed ID: 33222722
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rethinking
    Skally M; Bennett K; Humphreys H; Fitzpatrick F
    Euro Surveill; 2024 Feb; 29(6):. PubMed ID: 38333935
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.